In 2018:

  • additions and reversals on provisions amount to € 315 million and include the provision relating to the Group’s transformation restructuring program (€ 177 million);
  • use of provisions amounts to € (395) million, of which € (5) million for discontinued operations.

See note F34 Provisions for more information.

In 2017:

  • additions and reversals on provisions amounted to € 216 million;
  • use of provisions amounted to € (408) million, of which € (22) million for discontinued operations, mainly Polyamides.